Market open
Pulmatrix Inc./$PULM
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Pulmatrix Inc.
Pulmatrix Inc is a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).
Ticker
$PULM
Sector
Trading on
Industry
Pharmaceuticals
Headquarters
Employees
2
ISIN
US74584P3010
Website
Pulmatrix Inc. Metrics
BasicAdvanced
$22M
-
-$2.62
1.55
-
Price and volume
Market cap
$22M
Beta
1.55
52-week high
$8.70
52-week low
$5.12
Average daily volume
14K
Financial strength
Current ratio
10.678
Quick ratio
10.249
Management effectiveness
Return on assets (TTM)
-20.34%
Return on equity (TTM)
-70.96%
Valuation
Price to revenue (TTM)
2.849
Price to book
2.49
Price to tangible book (TTM)
2.49
Price to free cash flow (TTM)
-2.001
Growth
Revenue change (TTM)
6.96%
Earnings per share change (TTM)
-32.31%
3-year revenue growth (CAGR)
14.73%
3-year earnings per share growth (CAGR)
-32.81%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Pulmatrix Inc. stock?
Pulmatrix Inc. (PULM) has a market cap of $22M as of May 09, 2025.
What is the P/E ratio for Pulmatrix Inc. stock?
The price to earnings (P/E) ratio for Pulmatrix Inc. (PULM) stock is 0 as of May 09, 2025.
Does Pulmatrix Inc. stock pay dividends?
No, Pulmatrix Inc. (PULM) stock does not pay dividends to its shareholders as of May 09, 2025.
When is the next Pulmatrix Inc. dividend payment date?
Pulmatrix Inc. (PULM) stock does not pay dividends to its shareholders.
What is the beta indicator for Pulmatrix Inc.?
Pulmatrix Inc. (PULM) has a beta rating of 1.55. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.